Press releases

Regulatory

December 21, 2016

Oasmia Pharmaceutical Reports Positive Results from Study on Weekly Administration of Apealea® (Paclical®)

Regulatory

December 7, 2016

Oasmia Pharmaceutical AB’s Warrant Programs Fully Subscribed

Regulatory

December 2, 2016

Interim report for the period May – October 2016

Regulatory

November 22, 2016

Communiqué from Extraordinary General Meeting 2016

Regulatory

November 2, 2016

Nexttobe Extends Loan to Oasmia Pharmaceutical

Regulatory

November 1, 2016

Oasmia Pharmaceutical Announces Change in Ownership

Regulatory

October 31, 2016

Change in number of shares and voting rights in Oasmia Pharmaceutical AB (publ)

Regulatory

October 26, 2016

Oasmia convenes an extraordinary general meeting on the 21 November, 2016

Regulatory

October 24, 2016

Oasmia issues new shares for acquiring an asset corresponding to SEK 25 million

Regulatory

October 24, 2016

Oasmia successfully completes private placement of SEK 70 million

Regulatory

October 24, 2016

Oasmia Pharmaceutical intends to convene an extraordinary general meeting

Regulatory

October 24, 2016

Oasmia enters into collaboration agreement for novel cancer project

Regulatory

October 22, 2016

Oasmia announces private placement of new shares

Regulatory

October 21, 2016

Oasmia in discussions concerning acquisition of novel cancer project

Regulatory

September 27, 2016

Communiqué from Oasmia’s Annual General Meeting 2016

Regulatory

September 2, 2016

Interim report for the period May – July 2016

Regulatory

August 31, 2016

Oasmia Pharmaceutical AB Appoints Fredrik Gynnerstedt as Chief Financial Officer

Regulatory

August 26, 2016

Notice convening the Annual General Meeting of Shareholders in Oasmia Pharmaceutical AB

Regulatory

July 8, 2016

The Oasmia Pharmaceutical Annual Report is now published

Regulatory

February 2, 2016

Oasmia Pharmaceutical Makes Key Hires; Strengthens Organizational Structure Entering Commercial Phase